Clinical Medicine


  Listando 28 trabajos del autor/autora 38
Lista de trabajos en el área Clinical Medicine
Mentions   0   Wikipedia   60   News   0   Policy
Article HER2-enriched subtype as a predictor of pathological complete response following trastuzumab and lapatinib without chemotherapy in early-stage HER2-positive breast cancer (PAMELA): an open-label, single-group, multicentre, phase 2 trial Llombart-Cussac, Antonio; Cortes, Javier; Pare, Laia; Galvan, Patricia; Bermejo, Begona; Martinez, Noelia; Vidal, Maria; Pernas, Sonia; Lopez, Rafael; Munoz, Montserrat; Nuciforo, Paolo; Morales, Serafin; Oliveira, Mafalda; de la Pena, Lorena; Pelaez, Alex LANCET ONCOLOGY 1470-2045 (2017) DOI / 10.1016/s1470-2045(17)30021-9
Mentions   0   Wikipedia   37   News   0   Policy
Article A predictive model of pathologic response based on tumor cellularity and tumor-infiltrating lymphocytes (CelTIL) in HER2-positive breast cancer treated with chemo-free dual HER2 blockade Nuciforo, P.; Pascual, T.; Cortes, J.; Llombart-Cussac, A.; Fasani, R.; Pare, L.; Oliveira, M.; Galvan, P.; Martinez, N.; Bermejo, B.; Vidal, M.; Pernas, S.; Lopez, R.; Munoz, M.; Garau, I.; Manso, L.; Alarcon, J.; Martinez, E.; Rodrik-Outmezguine, V.; Bra ANNALS OF ONCOLOGY 0923-7534 (2018) DOI / 10.1093/annonc/mdx647 Bronze
Mentions   0   Wikipedia   9   News   0   Policy
Article Clinical, pathological, and PAM50 gene expression features of HER2-low breast cancer Schettini, Francesco; Chic, Nuria; Braso-Maristany, Fara; Pare, Laia; Pascual, Tomas; Conte, Benedetta; Martinez-Saez, Olga; Adamo, Barbara; Vidal, Maria; Barnadas, Esther; Fernandez-Martinez, Aranzazu; Gonzalez-Farre, Blanca; Sanfeliu, Esther; Cejalvo, Ju NPJ BREAST CANCER (2021) DOI / 10.1038/s41523-020-00208-2 Green published, Gold
Mentions   0   Wikipedia   5   News   0   Policy
Article HER2-Enriched Subtype and ERBB2 Expression in HER2-Positive Breast Cancer Treated with Dual HER2 Blockade Prat, Aleix; Pascual, Tomas; De Angelis, Carmine; Gutierrez, Carolina; Llombart-Cussac, Antonio; Wang, Tao; Cortes, Javier; Rexer, Brent; Pare, Laia; Forero, Andres; Wolff, Antonio C.; Morales, Serafin; Adamo, Barbara; Braso-Maristany, Fara; Vidal, Maria; JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE 0027-8874 (2020) DOI / 10.1093/jnci/djz042 Green published, Bronze
Mentions   0   Wikipedia   0   News   0   Policy
Article Gene expression profiles of breast cancer metastasis according to organ site Braso-Maristany, Fara; Pare, Laia; Chic, Nuria; Martinez-Saez, Olga; Pascual, Tomas; Mallafre-Larrosa, Meritxell; Schettini, Francesco; Gonzalez-Farre, Blanca; Sanfeliu, Esther; Martinez, Debora; Galvan, Patricia; Barnadas, Esther; Salinas, Belinda; Tolosa MOLECULAR ONCOLOGY 1574-7891 (2021) DOI / 10.1002/1878-0261.13021 Gold DOAJ
Mentions   0   Wikipedia   2   News   0   Policy
Article Association between PD1 mRNA and response to anti-PD1 monotherapy across multiple cancer types Pare, L.; Pascual, T.; Segui, E.; Teixido, C.; Gonzalez-Cao, M.; Galvan, P.; Rodriguez, A.; Gonzalez, B.; Cuatrecasas, M.; Pineda, E.; Torne, A.; Crespo, G.; Martin-Algarra, S.; Perez-Ruiz, E.; Reig, O.; Viladot, M.; Font, C.; Adamo, B.; Vidal, M.; Gaba, L ANNALS OF ONCOLOGY 0923-7534 (2018) DOI / 10.1093/annonc/mdy335 Bronze
Mentions   0   Wikipedia   0   News   0   Policy
Article Oestrogen receptor activity in hormone-dependent breast cancer during chemotherapy Chic, Nuria; Schettini, Francesco; Braso-Maristany, Fara; Sanfeliu, Esther; Adamo, Barbara; Vidal, Maria; Martinez, Debora; Galvan, Patricia; Gonzalez-Farre, Blanca; Cortes, Javier; Gavila, Joaquin; Saura, Cristina; Oliveira, Mafalda; Pernas, Sonia; Martin EBIOMEDICINE 2352-3964 (2021) DOI / 10.1016/j.ebiom.2021.103451 Green published, Gold
Mentions   0   Wikipedia   0   News   0   Policy
Article Phenotypic changes of HER2-positive breast cancer during and after dual HER2 blockade Braso-Maristany, Fara; Griguolo, Gaia; Pascual, Tomas; Pare, Laia; Nuciforo, Paolo; Llombart-Cussac, Antonio; Bermejo, Begona; Oliveira, Mafalda; Morales, Serafin; Martinez, Noelia; Vidal, Maria; Adamo, Barbara; Martinez, Olga; Pernas, Sonia; Lopez, Rafael NATURE COMMUNICATIONS (2020) DOI / 10.1038/s41467-019-14111-3 Gold DOAJ, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Article Circulating tumor DNA dynamics in advanced breast cancer treated with CDK4/6 inhibition and endocrine therapy Martinez-Saez, Olga; Pascual, Tomas; Braso-Maristany, Fara; Chic, Nuria; Gonzalez-Farre, Blanca; Sanfeliu, Esther; Rodriguez, Adela; Martinez, Debora; Galvan, Patricia; Rodriguez, Anna Belen; Schettini, Francesco; Conte, Benedetta; Vidal, Maria; Adamo, Bar NPJ BREAST CANCER (2021) DOI / 10.1038/s41523-021-00218-8 Gold DOAJ, Green published
Mentions   0   Wikipedia   1   News   0   Policy
Review HER2-enriched subtype and pathological complete response in HER2-positive breast cancer: A systematic review and meta-analysis Schettini, Francesco; Pascual, Tomas; Conte, Benedetta; Chic, Nuria; Braso-Maristany, Fara; Galvan, Patricia; Martinez, Olga; Adamo, Barbara; Vidal, Maria; Munoz, Montserrat; Fernandez-Martinez, Aranzazu; Rognoni, Carla; Griguolo, Gaia; Guarneri, Valentina CANCER TREATMENT REVIEWS 0305-7372 (2020) DOI / 10.1016/j.ctrv.2020.101965
Mentions   0   Wikipedia   1   News   0   Policy
Article A Prognostic Model Based on PAM50 and Clinical Variables (PAM50MET) for Metastatic Hormone Receptor-positive HER2-negative Breast Cancer Prat, Aleix; Tsai, Yi-Hsuan; Pascual, Tomas; Pare, Laia; Adamo, Barbara; Vidal, Maria; Braso-Maristany, Fara; Galvan, Patricia; Brase, Jan Christoph; Rodrik-Outmezguine, Vanessa; Johnston, Stephen; Ciruelos, Eva; Parker, Joel S. CLINICAL CANCER RESEARCH 1078-0432 (2020) DOI / 10.1158/1078-0432.ccr-20-2793
Mentions   0   Wikipedia   0   News   0   Policy
Article ERBB2mRNA Expression and Response to Ado-Trastuzumab Emtansine (T-DM1) in HER2-Positive Breast Cancer Griguolo, Gaia; Braso-Maristany, Fara; Gonzalez-Farre, Blanca; Pascual, Tomas; Chic, Nuria; Sauri, Tamara; Kates, Ronald; Gluz, Oleg; Martinez, Debora; Pare, Laia; Tsvetkova, Vassilena; Pesantez, David; Vidal, Maria; Adamo, Barbara; Munoz, Montserrat; Galv CANCERS (2020) DOI / 10.3390/cancers12071902 Gold DOAJ, Green published
Mentions   0   Wikipedia   2   News   0   Policy
Article Intrinsic Subtypes and Gene Expression Profiles in Primary and Metastatic Breast Cancer Cejalvo, Juan M.; de Duenas, Eduardo Martinez; Galvan, Patricia; Garcia-Recio, Susana; Gasion, Octavio Burgues; Pare, Laia; Antolin, Silvia; Martinello, Rosella; Blancas, Isabel; Adamo, Barbara; Guerrero-Zotano, Angel; Munoz, Montserrat; Nuciforow, Paolo; CANCER RESEARCH 0008-5472 (2017) DOI / 10.1158/0008-5472.can-16-2717 Bronze, Green accepted
Mentions   0   Wikipedia   0   News   0   Policy
Article Frequency and spectrum of PIK3CA somatic mutations in breast cancer Martinez-Saez, Olga; Chic, Nuria; Pascual, Tomas; Adamo, Barbara; Vidal, Maria; Gonzalez-Farre, Blanca; Sanfeliu, Esther; Schettini, Francesco; Conte, Benedetta; Braso-Maristany, Fara; Rodriguez, Adela; Martinez, Debora; Galvan, Patricia; Rodriguez, Ana Be BREAST CANCER RESEARCH 1465-542X (2020) DOI / 10.1186/s13058-020-01284-9 Gold DOAJ, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Article Significant Clinical Activity of Olaparib in a Somatic BRCA1-Mutated Triple-Negative Breast Cancer With Brain Metastasis Pascual, Tomas; Gonzalez-Farre, Blanca; Teixido, Cristina; Oleaga, Laura; Oses, Gabriela; Ganau, Sergi; Chic, Nuria; Riu, Gisela; Adamo, Barbara; Galvan, Patricia; Vidal, Maria; Soy, Dolors; Urbano, Alvaro; Munoz, Monserrat; Prat, Aleix JCO PRECISION ONCOLOGY (2019) DOI / 10.1200/po.19.00012
Mentions   0   Wikipedia   0   News   0   Policy
Article Oral metronomic vinorelbine combined with endocrine therapy in hormone receptor-positive HER2-negative breast cancer: SOLTI-1501 VENTANA window of opportunity trial Adamo, Barbara; Bellet, Meritxell; Pare, Laia; Pascual, Tomas; Vidal, Maria; Perez Fidalgo, Jose A.; Blanch, Salvador; Martinez, Noelia; Murillo, Laura; Gomez-Pardo, Patricia; Lopez-Gonzalez, Ana; Amillano, Kepa; Canes, Jordi; Galvan, Patricia; Gonzalez-Fa BREAST CANCER RESEARCH 1465-542X (2019) DOI / 10.1186/s13058-019-1195-z Gold DOAJ, Green published
Mentions   0   Wikipedia   1   News   0   Policy
Article Efficacy and Safety of Trastuzumab Emtansine Plus Capecitabine vs Trastuzumab Emtansine Alone in Patients With Previously Treated ERBB2 (HER2)-Positive Metastatic Breast Cancer A Phase 1 and Randomized Phase 2 Trial Cortes, Javier; Dieras, Veronique; Lorenzen, Sylvie; Montemurro, Filippo; Riera-Knorrenschild, Jorge; Thuss-Patience, Peter; Allegrini, Giacomo; De Laurentiis, Michelino; Lohrisch, Caroline; Oravcova, Eva; Perez-Garcia, Jose M.; Ricci, Francesco; Sakaeva, JAMA ONCOLOGY 2374-2437 (2020) DOI / 10.1001/jamaoncol.2020.1796 Green published, Gold other
Mentions   0   Wikipedia   0   News   0   Policy
Article SOLTI-1805 TOT-HER3 Study Concept: A Window-of-Opportunity Trial of Patritumab Deruxtecan, a HER3 Directed Antibody Drug Conjugate, in Patients With Early Breast Cancer Pascual, Tomas; Oliveira, Mafalda; Ciruelos, Eva; Bellet Ezquerra, Meritxell; Saura, Cristina; Gavila, Joaquin; Pernas, Sonia; Munoz, Montserrat; Vidal, Maria J.; Margeli Vila, Mireia; Cejalvo, Juan M.; Gonzalez-Farre, Blanca; Espinosa-Bravo, Martin; Cruz, FRONTIERS IN ONCOLOGY 2234-943X (2021) DOI / 10.3389/fonc.2021.638482 Gold DOAJ, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Article SOLTI-1503 PROMETEO TRIAL: combination of talimogene laherparepvec with atezolizumab in early breast cancer Pascual, Tomas; Cejalvo, Juan M.; Oliveira, Mafalda; Vidal, Maria; Vega, Estela; Ganau, Sergi; Julve, Ana; Zamora, Esther; Miranda, Ignacio; Delgado, Ana; Bermejo, Begona; de la Cruz-Merino, Luis; Juan, Manel; Ferrero-Cafiero, Juan M.; Canes, Jordi; Gonzal FUTURE ONCOLOGY 1479-6694 (2020) DOI / 10.2217/fon-2020-0246
Mentions   0   Wikipedia   0   News   0   Policy
Article Independent Validation of the PAM50-Based Chemo-Endocrine Score (CES) in Hormone Receptor-Positive HER2-Positive Breast Cancer Treated with Neoadjuvant Anti-HER2-Based Therapy Pascual, Tomas; Fernandez-Martinez, Aranzazu; Tanioka, Maki; Dieci, M. Vittoria; Pernas, Sonia; Gavila, Joaquin; Guarnieri, Valentina; Cortes, Javier; Villagrasa, Patricia; Chic, Nuria; Vidal, Maria; Adamo, Barbara; Munoz, Montserrat; Griguolo, Gaia; Llomb CLINICAL CANCER RESEARCH 1078-0432 (2021) DOI / 10.1158/1078-0432.ccr-20-4102 Bronze
Mentions   0   Wikipedia   0   News   0   Policy
Article A Pathology-Based Combined Model to Identify PAM50 Non-luminal Intrinsic Disease in Hormone Receptor-Positive HER2-Negative Breast Cancer Pascual, Tomas; Martin, Miguel; Fernandez-Martinez, Aranzazu; Pare, Laia; Alba, Emilio; Rodriguez-Lescure, Alvaro; Perrone, Giuseppe; Cortes, Javier; Morales, Serafin; Lluch, Ana; Urruticoechea, Ander; Gonzalez-Farre, Blanca; Galvan, Patricia; Jares, Pedro FRONTIERS IN ONCOLOGY 2234-943X (2019) DOI / 10.3389/fonc.2019.00303 Gold DOAJ, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Article Immune microenvironment characterisation and dynamics during anti-HER2-based neoadjuvant treatment in HER2-positive breast cancer Griguolo, G.; Serna, G.; Pascual, T.; Fasani, R.; Guardia, X.; Chic, N.; Pare, L.; Pernas, S.; Munoz, M.; Oliveira, M.; Vidal, M.; Llombart-Cussac, A.; Cortes, J.; Galvan, P.; Bermejo, B.; Martinez, N.; Lopez, R.; Morales, S.; Garau, I; Manso, L.; Alarcon, NPJ PRECISION ONCOLOGY (2021) DOI / 10.1038/s41698-021-00163-6 Gold DOAJ
Mentions   0   Wikipedia   0   News   0   Policy
Review Palbociclib and ribociclib in breast cancer: consensus workshop on the management of concomitant medication Bellet, Meritxell; Ahmad, Faten; Villanueva, Rafael; Valdivia, Carolina; Palomino-Doza, Julian; Ruiz, Ada; Gonzalez, Xavier; Adrover, Encarna; Azaro, Analia; Valls-Margarit, Maria; Lluis Parra, Josep; Aguilar, Juan; Vidal, Maria; Martin, Anastasi; Gavila, THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY 1758-8340 (2019) DOI / 10.1177/1758835919833867 Gold DOAJ, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Article Everolimus plus Exemestane for Hormone Receptor-Positive Advanced Breast Cancer: A PAM50 Intrinsic Subtype Analysis of BOLERO-2 Prat, Aleix; Christoph Brase, Jan; Cheng, Yuan; Nuciforo, Paolo; Pare, Laia; Pascual, Tomas; Martinez, Debora; Galvan, Patricia; Vidal, Maria; Adamo, Barbara; Hortobagyi, Gabriel N.; Baselga, Jose; Ciruelos, Eva ONCOLOGIST 1083-7159 (2019) DOI / 10.1634/theoncologist.2018-0407 Green published, Bronze
Mentions   0   Wikipedia   0   News   0   Policy
Article A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation Castroviejo-Bermejo, Marta; Cruz, Cristina; Llop-Guevara, Alba; Gutierrez-Enriquez, Sara; Ducy, Mandy; Hussein Ibrahim, Yasir; Gris-Oliver, Albert; Pellegrino, Benedetta; Bruna, Alejandra; Guzman, Marta; Rodriguez, Olga; Grueso, Judit; Bonache, Sandra; Mol EMBO MOLECULAR MEDICINE 1757-4676 (2018) DOI / 10.15252/emmm.201809172 Gold DOAJ, Green published
Mentions   0   Wikipedia   0   News   1   Policy
Article Safety of everolimus plus exemestane in patients with hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer: results of phase IIIb BALLET trial in Spain Ciruelos, E.; Vidal, M.; Martinez De Duenas, E.; Martinez-Janez, N.; Fernandez, Y.; Garcia-Saenz, J. A.; Murillo, L.; Carabantes, F.; Beliera, A.; Fonseca, R.; Gavila, J. CLINICAL & TRANSLATIONAL ONCOLOGY 1699-048X (2018) DOI / 10.1007/s12094-017-1784-1
Mentions   0   Wikipedia   0   News   0   Policy
Article Trastuzumab Emtansine Plus Non-Pegylated Liposomal Doxorubicin in HER2-Positive Metastatic Breast Cancer (Thelma): A Single-Arm, Multicenter, Phase Ib Trial Lopez-Miranda, Elena; Perez-Garcia, Jose Manuel; Di Cosimo, Serena; Brain, Etienne; Ravnik, Maja; Escriva-de-Romani, Santiago; Vidal, Maria; Gligorov, Joseph; Borstnar, Simona; Calabuig, Laura; Sampayo-Cordero, Miguel; Malfettone, Andrea; Llombart-Cussac, CANCERS (2020) DOI / 10.3390/cancers12123509 Green published, Gold other
Mentions   0   Wikipedia   0   News   0   Policy
Article Limitations in predicting PAM50 intrinsic subtype and risk of relapse score with Ki67 in estrogen receptor-positive HER2-negative breast cancer Fernandez-Martinez, Aranzazu; Pascual, Tomas; Perrone, Giuseppe; Morales, Serafin; de la Haba, Juan; Gonzalez-Rivera, Milagros; Galvan, Patricia; Zalfa, Francesca; Amato, Michela; Gonzalez, Lucia; Prats, Miquel; Rojo, Federico; Manso, Luis; Pare, Laia; Alo ONCOTARGET 1949-2553 (2017) DOI / 10.18632/oncotarget.15748 Bronze, Green published

Más rankings

InfluScience